Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study
Rocío A. López Zunini, Carole Scherling, Nancy Wallis, et al.
Brain Imaging and Behavior (2012) Vol. 7, Iss. 4, pp. 460-477
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults
Jeffrey S. Wefel, Shelli R. Kesler, Kyle R. Noll, et al.
CA A Cancer Journal for Clinicians (2014) Vol. 65, Iss. 2, pp. 123-138
Open Access | Times Cited: 457
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Journal of Pain and Symptom Management (2015) Vol. 50, Iss. 6, pp. 830-841
Open Access | Times Cited: 153
Chemotherapy, cognitive impairment and hippocampal toxicity
Jörg Dietrich, Morgan Prust, Jochen Kaiser
Neuroscience (2015) Vol. 309, pp. 224-232
Closed Access | Times Cited: 133
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 83, pp. 417-428
Closed Access | Times Cited: 132
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment — The role of fatigue
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
NeuroImage Clinical (2015) Vol. 7, pp. 547-554
Open Access | Times Cited: 119
Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls
Shelli R. Kesler, Jeffrey S. Wefel, S. M. Hadi Hosseini, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 28, pp. 11600-11605
Open Access | Times Cited: 107
Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review
Mingmei Li, Karen Caeyenberghs
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 304-317
Closed Access | Times Cited: 107
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments
Jéssica Cristina dos Santos, Leah M. Pyter
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 100
Monitoring and optimising cognitive function in cancer patients: Present knowledge and future directions
S.B. Schagen, Martin Klein, Jaap C. Reijneveld, et al.
European Journal of Cancer Supplements (2014) Vol. 12, Iss. 1, pp. 29-40
Open Access | Times Cited: 97
Default mode network as a potential biomarker of chemotherapy-related brain injury
Shelli R. Kesler
Neurobiology of Aging (2014) Vol. 35, pp. S11-S19
Open Access | Times Cited: 94
A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients
Christian Lepage, Andra Smith, Jeremy T. Moreau, et al.
SpringerPlus (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 94
Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-related Post-traumatic Stress
Kerstin Hermelink, Varinka Voigt, Judith Kaste, et al.
JNCI Journal of the National Cancer Institute (2015) Vol. 107, Iss. 7, pp. djv099-djv099
Open Access | Times Cited: 90
Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”
Erin O’Farrell, Joyce MacKenzie, Barbara Collins
Current Oncology Reports (2013) Vol. 15, Iss. 3, pp. 260-269
Closed Access | Times Cited: 78
Longitudinal Assessment of Chemotherapy-Induced Alterations in Brain Activation During Multitasking and Its Relation With Cognitive Complaints
Sabine Deprez, Mathieu Vandenbulcke, Ronald Peeters, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 19, pp. 2031-2038
Open Access | Times Cited: 72
Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging
Yun Feng, Xiao Dong Zhang, Gang Zheng, et al.
Brain Imaging and Behavior (2019) Vol. 13, Iss. 6, pp. 1799-1814
Closed Access | Times Cited: 59
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Opening up the Window into “Chemobrain”: A Neuroimaging Review
Carole Scherling, Andra Smith
Sensors (2013) Vol. 13, Iss. 3, pp. 3169-3203
Open Access | Times Cited: 62
Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns
Alexandra C. Apple, Anthony J. Ryals, Kathryn I. Alpert, et al.
NeuroImage Clinical (2017) Vol. 14, pp. 685-691
Open Access | Times Cited: 53
Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type
Sanne Menning, Michiel B. de Ruiter, Dick J. Veltman, et al.
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0171724-e0171724
Open Access | Times Cited: 51
The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies
Helena Sousa, Susana Almeida, João M. Bessa, et al.
Neuropsychology Review (2020) Vol. 30, Iss. 3, pp. 287-309
Open Access | Times Cited: 46
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research
Andrew J. Saykin, Michiel B. de Ruiter, Brenna C. McDonald, et al.
Brain Imaging and Behavior (2013) Vol. 7, Iss. 4, pp. 363-373
Open Access | Times Cited: 50
Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
Denise D. Correa, James C. Root, Maria Kryza‐Lacombe, et al.
Brain Imaging and Behavior (2016) Vol. 11, Iss. 6, pp. 1652-1663
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top